Silo Pharma, Inc. to acquire Larry King

Silo Pharma, Inc. has completed the acquisition of assets from Larry King. The transaction, which was announced on 14 October 2026, was finalized on 13 October 2026. Both the buyer and the target are based in the United States. The deal is classified as an asset sale within the healthcare sector. Silo Pharma paid for the assets using shares as the sole form of consideration. The specific financial value of the transaction has not been disclosed.

The completion date precedes the announcement date, indicating that the deal was finalized before being made public. This structure suggests a private agreement that was subsequently reported to stakeholders. No further details regarding the specific assets transferred or the strategic rationale behind the acquisition are provided in the available records. The transaction is now considered completed, with no pending regulatory approvals or subsequent steps reported. The use of equity as consideration aligns with common practices in corporate acquisitions where cash preservation is a priority.